Table 1 Baseline characteristics and delays of included patients
From: Management strategies and outcomes of acute coronary syndrome (ACS) during Covid-19 pandemic
Variables | COVID-19 group (n = 171) | pre-COVID-19 group (n = 52) | p |
|---|---|---|---|
Age (yrs) | 64.0 ± 13.1 | 64.4 ± 13.5 | 0.85 |
Gender (male), n (%) | 142 (83.0) | 42 (80.7) | 0.77 |
BMI (kg/m2) | 21.5 ± 3.2 | 22.3 ± 4.0 | 0.81 |
SBP (mmHg) | 124.60 ± 25.12 | 127.72 ± 30.90 | 0.44 |
DBP (mmHg) | 78.59 ± 17.22 | 80.21 ± 18.62 | 0.55 |
Hypertension, n (%) | 87 (50.9) | 26 (50.0) | 0.88 |
Diabetes mellitus, n (%) | 36 (21.1) | 12 (23.1) | 0.12 |
Smoker, n (%) | 110 (64.3) | 34 (65.4) | 0.87 |
Congestive cardiac failure, n (%) | 2 (1.1) | 1(1.9) | 0.68 |
Atrial fibrillation, n (%) | 3 (1.7) | 2 (3.8) | 0.39 |
Previous MI, n (%) | 12 (7.0) | 5(9.6) | 0.48 |
Previous PCI, n (%) | 8 (5.3) | 3 (5.8) | 0.86 |
Cerebrovascular disease or peripheral vascular disease, n (%) | 20 (1.7) | 8 (15.3) | 0.66 |
Average FMC, min | 625.3 | 1176.9 | 0.001* |
Proportion of FMC within 2Â h, n (%) | 51 (29.8) | 14 (26.9) | 0.57 |
Time to worsen symptoms prior to entry (hrs) | 10.15 ± 9.04 | 11.63 ± 10.61 | 0.68 |
Proportion of transferred patients, n (%) | 105 (61.4) | 37 (71.1) | 0.04* |
Catheter activation, min | 5.29 ± 11.86 | 4.55 ± 7.01 | 0.65 |
Average D2B, min | 84.3 | 107.1 | 0.28 |
Proportion of D2B within 90Â min, n (%) | 106 (61.9) | 24 (46.1) | 0.04* |
The time from arrival to puncture, min | 10.3 ± 7.8 | 12.9 ± 11.8 | 0.21 |
The guide wire crossing time, min | 28.5 ± 11.4 | 21.9 ± 9.4 | 0.02* |
Duration of operation, min | 52.9 ± 22.7 | 44.0 ± 19.6 | 0.02* |